Psychemedics Corporation
PMDI
$2.30
$0.000.00%
| Weiss Ratings | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.22 | |||
| Price History | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.22% | |||
| 30-Day Total Return | 15.00% | |||
| 60-Day Total Return | -28.35% | |||
| 90-Day Total Return | -0.48% | |||
| Year to Date Total Return | 10.05% | |||
| 1-Year Total Return | -22.82% | |||
| 2-Year Total Return | -62.84% | |||
| 3-Year Total Return | -62.33% | |||
| 5-Year Total Return | -67.22% | |||
| 52-Week High % Change | -30.09% | |||
| 52-Week Low % Change | 107.21% | |||
| Price | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.29 | |||
| 52-Week Low Price | $1.11 | |||
| 52-Week Low Price (Date) | Dec 13, 2024 | |||
| 52-Week High Price (Date) | Mar 11, 2024 | |||
| Valuation | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 14.05M | |||
| Enterprise Value | 14.23M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.51 | |||
| Earnings Per Share Growth | -24.45% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.67 | |||
| Price/Book (Q) | 2.49 | |||
| Enterprise Value/Revenue (TTM) | 0.70 | |||
| Price | $2.30 | |||
| Enterprise Value/EBITDA (TTM) | -7.54 | |||
| Enterprise Value/EBIT | -4.86 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 5.89M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.07 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 0.00% | |||
| Dividend Per Share (Most Recent) | $0.07 | |||
| Company Info | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (800) 527-7424 | |||
| Address | 5220 Spring Valley Road Dallas, TX 75254 | |||
| Website | www.psychemedics.com | |||
| Country | United States | |||
| Year Founded | 1986 | |||
| Profitability | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -14.45% | |||
| Profit Margin | -14.78% | |||
| Management Effectiveness | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -15.29% | |||
| Return on Equity | -- | |||
| Income Statement | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 20.26M | |||
| Total Revenue (TTM) | 20.26M | |||
| Revenue Per Share | $3.44 | |||
| Gross Profit (TTM) | 7.77M | |||
| EBITDA (TTM) | -1.89M | |||
| EBIT (TTM) | -2.93M | |||
| Net Income (TTM) | -3.00M | |||
| Net Income Avl. to Common (TTM) | -3.00M | |||
| Total Revenue Growth (Q YOY) | -9.27% | |||
| Earnings Growth (Q YOY) | 74.51% | |||
| EPS Diluted (TTM) | -0.51 | |||
| EPS Diluted Growth (Q YOY) | 75.10% | |||
| Balance Sheet | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.41M | |||
| Cash Per Share (Q) | $0.24 | |||
| Total Current Assets (Q) | 6.05M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.45M | |||
| Current Ratio (Q) | 1.594 | |||
| Book Value Per Share (Q) | $0.92 | |||
| Total Assets (Q) | 9.84M | |||
| Total Current Liabilities (Q) | 3.79M | |||
| Total Debt (Q) | 1.58M | |||
| Total Liabilities (Q) | 4.39M | |||
| Total Common Equity (Q) | 5.45M | |||
| Cash Flow | PMDI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 39.00K | |||
| Cash from Financing (TTM) | -576.00K | |||
| Net Change in Cash (TTM) | 35.00K | |||
| Levered Free Cash Flow (TTM) | 1.92M | |||
| Cash from Operations (TTM) | 572.00K | |||
